| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |